PDF) Sublingual Sufentanil Tablet System (SSTS-Zalviso®) for Postoperative Analgesia after Orthopedic Surgery: A Retrospective Study
Zalviso Sublingual Tablet System Instructions for Use Rev K PDF download
Sublingual sufentanil tablet system Zalviso® for postoperative analgesia after knee replacement in fast track surgery: a pilot observational study | Journal of Experimental Orthopaedics | Full Text
ACELRX PHARMACEUTICALS, INC.
acrx20171231_10k.htm
JCM | Free Full-Text | Sublingual Sufentanil Tablet System (SSTS-Zalviso®) for Postoperative Analgesia after Orthopedic Surgery: A Retrospective Study
ARX2006 Zalviso hand-held patient controlled analgesia (PCA) system User Manual Manual 1/4 AcelRx Pharmaceuticals .
Zalviso, INN-sufentanil
ARX2006 Zalviso hand-held patient controlled analgesia (PCA) system User Manual Manual 1/4 AcelRx Pharmaceuticals .
Sufentanil sublingual tablet system with radio-frequency identification... | Download Scientific Diagram
Dispensing of minitablets – Has the problem been resolved? - ScienceDirect
SEC Filing | AcelRx Pharmaceuticals, Inc.
JCM | Free Full-Text | Sublingual Sufentanil Tablet System (SSTS-Zalviso®) for Postoperative Analgesia after Orthopedic Surgery: A Retrospective Study
Dispensing of minitablets – Has the problem been resolved? - ScienceDirect
Zalviso Sublingual Tablet System Instructions for Use Rev K PDF download
Acelrx Pharmaceuticals Annual Report 2020
EX-10.29
SEC Filing | AcelRx Pharmaceuticals, Inc.
ARX2006 Zalviso hand-held patient controlled analgesia (PCA) system User Manual Manual 1/4 AcelRx Pharmaceuticals .
Red Dot Design Award: Zalviso®
ARX2006 Zalviso hand-held patient controlled analgesia (PCA) system User Manual Manual 2/4 AcelRx Pharmaceuticals .
Sufentanil Sublingual Tablet System vs. Intravenous Patient‐Controlled Analgesia with Morphine for Postoperative Pain Control: A Randomized, Active‐Comparator Trial - Melson - 2014 - Pain Practice - Wiley Online Library
A Multicenter, Open-Label Trial to Evaluate the Overall Performance of the Zalviso System (sufentanil sublingual tablet system)
PDL BioPharma Acquires a Portion of AcelRx Pharmaceuticals' Expected Royalties and Commercial Milestones from Zalviso™ for $65 Million | PDL BioPharma, Inc.
ACELRX PHARMACEUTICALS, INC.
